0001104659-23-062834.txt : 20230519 0001104659-23-062834.hdr.sgml : 20230519 20230519214139 ACCESSION NUMBER: 0001104659-23-062834 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230405 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chaturvedi Pravin R CENTRAL INDEX KEY: 0001916935 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 23942267 MAIL ADDRESS: STREET 1: C/O JAGUAR HEALTH INC., 200 PINE STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 4/A 1 tm2316214-10_4aseq1.xml OWNERSHIP DOCUMENT X0407 4/A 2023-04-05 2023-04-20 0 0001585608 Jaguar Health, Inc. JAGX 0001916935 Chaturvedi Pravin R C/O JAGUAR HEALTH, INC. 200 PINE STREET, SUITE 400 SAN FRANCISCO CA 94104 0 1 0 0 Chief Scientific Officer 0 Common Stock 2023-04-05 4 M 0 133 A 266 D Restricted stock units 2023-04-05 4 A 0 133 0 A Common Stock 133 134 D Restricted stock units convert into common stock on a one-for-one basis. On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "September 2021 Reverse Stock Split"). Upon effectiveness of the September 2021 Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock. On April 20, 2023, the reporting person filed a Form 4 that erroneously indicated that 44 restricted stock units had vested on April 5, 2023 and the reporting person beneficially owned 44 restricted stock units and 88 shares of common stock following such vesting. In fact, 133 restricted stock units had vested on such date and the reporting person beneficially owned 134 restricted stock units and 266 shares of common stock following such vesting. /s/ Pravin R. Chaturvedi 2023-05-19